To demonstrate contribution of CD4+ T cells to A20-silenced BMMф-triggered immune protection, OT-II-pulsed, A20-silenced BMMфs were used to immunize CD4−/−mice and the wildtype littermates followed by a challenge of melanoma M05 cells two weeks after the 2nd immunization. Here, CD4 is linked to melanoma.